• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与腹膜透析相关腹膜炎相关的危险因素。

Risk factors associated with peritoneal-dialysis-related peritonitis.

作者信息

Kerschbaum Julia, König Paul, Rudnicki Michael

机构信息

Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria.

出版信息

Int J Nephrol. 2012;2012:483250. doi: 10.1155/2012/483250. Epub 2012 Dec 20.

DOI:10.1155/2012/483250
PMID:23320172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3539329/
Abstract

Background. Peritonitis represents a major complication of peritoneal dialysis (PD). The aim of this paper was to systematically collect data on patient-related risk factors for PD-associated peritonitis, to analyze the methodological quality of these studies, and to summarize published evidence on the particular risk factors. Methods. Studies were identified by searches of Pubmed (1990-2012) and assessed for methodological quality by using a modified form of the STROBE criteria. Results. Thirty-five methodologically acceptable studies were identified. The following nonmodifiable risk factors were considered valid and were associated with an increased risk of peritonitis: ethnicity, female gender, chronic lung disease, coronary artery disease, congestive heart failure, cardiovascular disease, hypertension, antihepatitis C virus antibody positivity, diabetes mellitus, lupus nephritis or glomerulonephritis as underlying renal disease, and no residual renal function. We also identified the following modifiable, valid risk factors for peritonitis: malnutrition, overweight, smoking, immunosuppression, no use of oral active vitamin D, psychosocial factors, low socioeconomic status, PD against patient's choice, and haemodialysis as former modality. Discussion. Modifiable and nonmodifiable risk factors analyzed in this paper might serve as a basis to improve patient care in peritoneal dialysis.

摘要

背景。腹膜炎是腹膜透析(PD)的主要并发症。本文旨在系统收集与腹膜透析相关腹膜炎患者相关危险因素的数据,分析这些研究的方法学质量,并总结关于特定危险因素的已发表证据。方法。通过检索Pubmed(1990 - 2012年)确定研究,并使用改良版的STROBE标准评估方法学质量。结果。确定了35项方法学上可接受的研究。以下不可改变的危险因素被认为是有效的,且与腹膜炎风险增加相关:种族、女性、慢性肺病、冠状动脉疾病、充血性心力衰竭、心血管疾病、高血压、抗丙型肝炎病毒抗体阳性、糖尿病、潜在肾病为狼疮性肾炎或肾小球肾炎以及无残余肾功能。我们还确定了以下可改变的、有效的腹膜炎危险因素:营养不良、超重、吸烟、免疫抑制、未使用口服活性维生素D、社会心理因素、社会经济地位低、违背患者意愿进行腹膜透析以及既往接受血液透析治疗。讨论。本文分析的可改变和不可改变的危险因素可能为改善腹膜透析患者护理提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb6/3539329/9e10ef273695/IJN2012-483250.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb6/3539329/6a2083f10b37/IJN2012-483250.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb6/3539329/9e10ef273695/IJN2012-483250.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb6/3539329/6a2083f10b37/IJN2012-483250.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bb6/3539329/9e10ef273695/IJN2012-483250.002.jpg

相似文献

1
Risk factors associated with peritoneal-dialysis-related peritonitis.与腹膜透析相关腹膜炎相关的危险因素。
Int J Nephrol. 2012;2012:483250. doi: 10.1155/2012/483250. Epub 2012 Dec 20.
2
Serum 25-Hydroxyvitamin D Level Could Predict the Risk for Peritoneal Dialysis-Associated Peritonitis.血清25-羟基维生素D水平可预测腹膜透析相关腹膜炎的风险。
Perit Dial Int. 2015 Dec;35(7):729-35. doi: 10.3747/pdi.2014.00177. Epub 2015 Jul 29.
3
Characteristics, complications and outcome of patients treated with automated peritoneal dialysis at the Peritoneal Dialysis Unit, University Hospital of the West Indies.西印度群岛大学医院腹膜透析科接受自动化腹膜透析治疗患者的特征、并发症及治疗结果
West Indian Med J. 2010 Jun;59(3):312-8.
4
Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study.腹膜透析第一年的技术失败风险预测因素和原因:澳大利亚和新西兰透析和移植登记处(ANZDATA)研究。
Am J Kidney Dis. 2018 Aug;72(2):188-197. doi: 10.1053/j.ajkd.2017.10.019. Epub 2017 Dec 23.
5
Risk factors for peritonitis in pediatric peritoneal dialysis: a single-center study.小儿腹膜透析腹膜炎的危险因素:一项单中心研究。
Pediatr Nephrol. 2005 Oct;20(10):1478-83. doi: 10.1007/s00467-005-1953-2. Epub 2005 Aug 5.
6
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients.慢性腹膜透析患者预防导管相关感染的导管类型、放置及插入技术
Cochrane Database Syst Rev. 2019 May 31;5(5):CD004680. doi: 10.1002/14651858.CD004680.pub3.
7
Surgical Complications of Peritoneal Dialysis.腹膜透析的手术并发症
Chirurgia (Bucur). 2018 Sept-Oct;113(5):611-624. doi: 10.21614/chirurgia.113.5.611.
8
Current Practice and Outcomes of Peritoneal Dialysis in the Nippon Medical School Musashi Kosugi Hospital.日本医科大学武藏小杉医院腹膜透析的当前实践与结果
J Nippon Med Sch. 2018;85(2):102-109. doi: 10.1272/jnms.2018_85-16.
9
Mannose binding lectin level and polymorphism in patients on long-term peritoneal dialysis.长期腹膜透析患者的甘露糖结合凝集素水平及多态性
Nephrol Dial Transplant. 2005 Nov;20(11):2489-96. doi: 10.1093/ndt/gfi089. Epub 2005 Aug 22.
10
Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).腹膜透析相关感染率和结局:来自腹膜透析结局和实践模式研究(PDOPPS)的结果。
Am J Kidney Dis. 2020 Jul;76(1):42-53. doi: 10.1053/j.ajkd.2019.09.016. Epub 2020 Jan 10.

引用本文的文献

1
Text mining for case report articles on "peritoneal dialysis" from PubMed database.从PubMed数据库中挖掘关于“腹膜透析”的病例报告文章。
Ther Apher Dial. 2025 Jun;29(3):459-470. doi: 10.1111/1744-9987.70013. Epub 2025 Mar 26.
2
Improving peritoneal dialysis fluid culture-positivity yield from 2022 to 2023.2022年至2023年提高腹膜透析液培养阳性率
S Afr J Infect Dis. 2024 Nov 29;39(1):684. doi: 10.4102/sajid.v39i1.684. eCollection 2024.
3
Peritoneal dialysis-related infections in elderly patients.老年患者腹膜透析相关性感染。

本文引用的文献

1
Obligatory referral among other factors associated with peritonitis in peritoneal dialysis patients.强制性转介与其他因素与腹膜透析患者腹膜炎相关。
Nefrologia. 2011;31(4):435-40. doi: 10.3265/Nefrologia.pre2011.Apr.10796.
2
Sevelamer use and incidence of peritonitis in peritoneal dialysis.司维拉姆的使用与腹膜透析相关性腹膜炎的发生。
Wien Klin Wochenschr. 2011 Apr;123(7-8):204-8. doi: 10.1007/s00508-011-1551-1. Epub 2011 Mar 28.
3
Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality.
Clin Exp Nephrol. 2024 Nov;28(11):1065-1074. doi: 10.1007/s10157-024-02531-5. Epub 2024 Jun 25.
4
Diagnostic Accuracy of MMP-8 and IL-6-Based Point-of-Care Testing to Detect Peritoneal Dialysis-Related Peritonitis: A Single-Center Experience.基于基质金属蛋白酶-8和白细胞介素-6的即时检测对腹膜透析相关性腹膜炎的诊断准确性:单中心经验
Diagnostics (Basel). 2024 May 27;14(11):1113. doi: 10.3390/diagnostics14111113.
5
Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis.在持续不卧床腹膜透析患者中,血清 iPTH 与腹膜炎发作之间的关系。
Front Endocrinol (Lausanne). 2023 Mar 27;14:1081543. doi: 10.3389/fendo.2023.1081543. eCollection 2023.
6
Excessive risk and poor outcome of hospital-acquired peritoneal dialysis-related peritonitis.医院获得性腹膜透析相关腹膜炎的风险过高及预后不良。
Clin Kidney J. 2022 Jul 4;15(11):2107-2115. doi: 10.1093/ckj/sfac164. eCollection 2022 Nov.
7
Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients.基线腹膜转运特性与新发腹膜透析患者的腹膜炎风险相关。
Membranes (Basel). 2022 Feb 28;12(3):276. doi: 10.3390/membranes12030276.
8
The prevalence and bacterial distribution of peritonitis amongst adults undergoing continuous ambulatory peritoneal dialysis at Universitas hospital.尤尼弗西塔斯医院接受持续性非卧床腹膜透析的成年人腹膜炎的患病率及细菌分布情况
S Afr J Infect Dis. 2020 Mar 16;35(1):104. doi: 10.4102/sajid.v35i1.104. eCollection 2020.
9
Peritoneal transport status and first episode of peritonitis: a large cohort study.腹膜转运状态与首次腹膜炎发作:一项大型队列研究。
Ren Fail. 2021 Dec;43(1):1094-1103. doi: 10.1080/0886022X.2021.1949350.
10
Differences in the quality of life of chronic kidney disease patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis.接受血液透析和持续性非卧床腹膜透析的慢性肾病患者的生活质量差异。
J Public Health Res. 2021 Apr 14;10(2):2209. doi: 10.4081/jphr.2021.2209.
远程原住民腹膜透析患者发生腹膜炎、技术失败、全因和腹膜炎相关死亡率的风险更高。
Nephrol Dial Transplant. 2011 Oct;26(10):3366-72. doi: 10.1093/ndt/gfr070. Epub 2011 Mar 7.
4
Predictor factors of peritoneal dialysis-related peritonitis.腹膜透析相关性腹膜炎的预测因素。
J Bras Nefrol. 2010 Apr-Jun;32(2):156-64.
5
Peritonitis and exit site infections in First Nations patients on peritoneal dialysis.第一民族腹膜透析患者的腹膜炎和出口部位感染。
Clin J Am Soc Nephrol. 2010 Nov;5(11):1988-95. doi: 10.2215/CJN.04170510. Epub 2010 Aug 19.
6
Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin d.腹膜透析相关性腹膜炎的危险因素:口服活性维生素 D 的作用。
Perit Dial Int. 2010 Sep-Oct;30(5):541-8. doi: 10.3747/pdi.2009.00108. Epub 2010 Mar 12.
7
Is decline in serum albumin an ominous sign for subsequent peritonitis in peritoneal dialysis patients?血清白蛋白下降对腹膜透析患者随后发生腹膜炎来说是一个不祥之兆吗?
Adv Perit Dial. 2009;25:172-7.
8
Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database.腹膜透析患者腹膜炎的预测因素:来自加拿大一个大型前瞻性数据库的结果
Clin J Am Soc Nephrol. 2009 Jul;4(7):1195-200. doi: 10.2215/CJN.00910209. Epub 2009 Apr 30.
9
Impact of age on peritonitis risk in peritoneal dialysis patients: an era effect.年龄对腹膜透析患者腹膜炎风险的影响:时代效应
Clin J Am Soc Nephrol. 2009 Jan;4(1):135-41. doi: 10.2215/CJN.02060508. Epub 2008 Nov 5.
10
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.《流行病学观察性研究报告强化(STROBE)声明》:观察性研究报告指南
Lancet. 2007 Oct 20;370(9596):1453-7. doi: 10.1016/S0140-6736(07)61602-X.